3 results · Page 1 of 1

Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 2A/B Efficacy and Safety of Dabogratinib in Participants With Low Grade Upper Tract Urothelial CarcinomaLow Grade Upper Tract Urothelial CarcinomaRecruitingPhase 22026-10-02NCT07265947
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate ThrombocytopeniaCytopenia, Hemic and Lymphatic Diseases, Myeloproliferative Disorders, blood platelet disease, bone marrow disorder, hematologic disorder, primary myelofibrosis, thrombocytopeniaRecruitingPhase 22026-02-12NCT05980806
Plant vs Animal-based Protein Sources as an Anabolic and Metabolic-protective Options for SO in Older AdultsAtrophy, Body Weight, Neurologic Manifestations, Neuromuscular Manifestations, Nutritional and Metabolic Diseases, Overweight, Pathological Conditions, Anatomical, Pathological Conditions, Signs and Symptoms, Sarcopenia, Signs and Symptoms, muscular atrophy, nervous system disorder, nutritional disorder, obesity disorder, overnutritionNot yet recruitingNot applicable2025-06-22NCT07030738